Roberto Gramignoli, MSc, PhD
Specialization as Qualified Person
Roberto has over 20 years of experience working in academia, with a primary interest in investigating human liver biology, pathology, and disease. During his career, Roberto has played a prominent role in planning, developing and finalizing all the methodological and regulatory issues to translate cellular therapies into clinics, first in Italy, then in the USA, and now at Karolinska Institute.
At the Karolinska Institute, his group is active in translating such new stem cell therapy to the clinic, where for the first time, they can inject primary allogenic stem cells without immunosuppression in support.